SYMBRAVO 20-10 MG TABLET

meloxicam, rizatriptan
$122.7150per EA

Strength

20; 10 mg/1; mg/1

NDC

81968002009

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA215431

On Market Since

5/19/2025

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

+0.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

+0.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.